Fish Oils: Clinical Trials

69 trials of Fish Oils, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

48 completed, 8 terminated, 5 unknown, 4 recruiting. 69 Phase 2, 10 Phase 3, 8 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 269Completed 48, Terminated 8, Unknown 5, Recruiting 4, Withdrawn 3, Active not recruiting 1
Phase 310Completed 7, Recruiting 1, Terminated 1, Unknown 1
Phase 18Completed 6, Terminated 1, Withdrawn 1

Follow Fish Oils: new trials by email Literature Review of Fish Oils trials Research Report on Fish Oils

Trials (filtered) newest first · largest first

All 69 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
FISH OIL 500MG OMEGA-3 SOFT GEL MINIS, Placebo - Dermatomyositis (DM), Juvenile Dermatomyositis (JDM)
Phase 2RecruitingNational Institute of Environmental Health Sciences (NIEHS)30002026-11-122026-11-09
Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults
Fish Oil, Corn oil control - Type 2 Diabetes, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
Phase 2RecruitingMay Faraj, PDt, PhD842026-10-052026-10-08
Perinatal Depression & Anxiety (PDA) and Maternal Gut Microbiome
Fish oil, Probiotics, Prebiotics - Perinatal Depression, PerinatalAnxiety
Phase 2 / Phase 3RecruitingThe Canadian College of Naturopathic Medicine1002024-08-152024-08-27
the Effects of Fish Oil Supplements on Choroidal Thickness and Blood Flow Perfusion in Children and Adolescents
fish oil - Fish Oils
Phase 2CompletedShanghai Eye Disease Prevention and Treatment Center382024-07-212025-03-14
Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients
Fish Oil, Intravenous 0.9% Sodium Chloride - Intensive Care Unit, Coronary Artery Bypass Grafting (CABG)
Phase 2RecruitingGCP-Service International West GmbH5502024-02-152026-07-08
Supplements, Placebo, or Rosuvastatin Study
Fish Oil, Cinnamon, Garlique,Turmeric, Plant Sterol, Red Yeast Rice, Rosuvastatin, Placebo - Hypercholesterolemia
Phase 2CompletedThe Cleveland Clinic2032021-04-232023-05-25
A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)
ORMD-0801 (Insulin) capsule 8 mg BD, Placebo - Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis
Phase 2CompletedOramed, Ltd.322020-11-242024-08-07
A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes Mellitus
ORMD-0801, Placebo - Diabetes Mellitus, Type 2
Phase 2CompletedOramed, Ltd.492020-11-232024-05-07
Omega-3 Fatty Acids for Smoking Cessation in Pregnancy
Fish Oil (Containing Omega-3 Acids), Olive Oil - Preterm Labor, Tobacco Use Disorder
Phase 2CompletedVanderbilt University Medical Center2372020-11-102026-06-04
Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH
lipid injectable emulsion with Fish oil - Pulmonary Hypertension of Newborn, Diaphragm Defect
Phase 2Active not recruitingCoordinación de Investigación en Salud, Mexico402019-08-122026-11-02
Bioavailability of EPA + DHA Enriched Canned Tuna and Its Acute Effects
Meal containing canned tuna + fish oil (5 g EPA + DHA), Meal containing canned tuna + soybean oil - Healthy Volunteers
Phase 2UnknownUniversidade do Porto282018-09-192019-05-30
Vitamin D and n-3 Polyunsaturated Fatty Acids (PUFAs) to Prevent Chronic Pain Following Major Thermal Burn Injury
Omega-3 fatty acids (fish oil), Vitamin D3 (cholecalciferol), Vitamin D3 (cholecalciferol) placebo - Chronic Pain Following Thermal Burn Injury
Phase 2TerminatedUniversity of North Carolina, Chapel Hill242018-07-192026-05-08
A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus
Cohort A: ORMD-0801, Placebo oral capsule, Cohort B: ORMD-0801 - T2DM (Type 2 Diabetes Mellitus)
Phase 2CompletedOramed, Ltd.3732018-05-292022-11-08
OPTIMA-TBI Pilot Study
Omega-3 Polyunsaturated Fatty Acids (Fish Oil 1000 mg (contains 500 mg DHA & 100 mg EPA)) or placebo capsules., Placebo - Cap - Mild Traumatic Brain Injury
Phase 2TerminatedUniversity of Michigan442017-09-122023-05-23
Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults
control fish oil, LCMUFA-rich saury oil - Lipoprotein Metabolism, PCSK9
Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)372017-06-152020-08-12
Omega-3 Plus Low-dose Aspirin Daily Supplementation in Non-surgical Therapy to Treat Aggressive Periodontitis
Omega-3 polyunsaturated fatty acids, Aspirin, Placebo - Aggressive Periodontitis
Phase 2 / Phase 3CompletedUniversidade Estadual Paulista Júlio de Mesquita Filho382017-05-152021-12-28
Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis
Open flap debridement, Placebo, Omega-3 polyunsaturated fatty acids - Residual Disease, Aggressive Periodontitis
Phase 2 / Phase 3CompletedUniversidade Estadual Paulista Júlio de Mesquita Filho342017-05-152020-11-17
Fish Oil to Reduce Tobacco Use iN Expectant Mothers Study
Fish oil, Placebos - Tobacco Use in Childbirth, Smoking Cessation
Phase 2CompletedVanderbilt University Medical Center282017-03-022019-01-09
A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus
ORMD-0801 (qd), ORMD-0801 (bid), ORMD-0801 (tid) - Type 2 Diabetes Mellitus
Phase 2CompletedOramed, Ltd.312016-10-012018-07-12
The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study
Omega-3 fish oil, Losartan, Corn Oil (Fish oil Placebo) - Inflammation
Phase 2CompletedUniversity of Florida2892016-04-262024-05-07

Showing 20 of 69. Sign in to see all of them.

Conditions studied

Inflammation (8)  ·  Diabetes Mellitus, Type 2 (7)  ·  Cardiovascular Diseases (4)  ·  Insulin Resistance (4)  ·  Non-alcoholic Fatty Liver Disease (4)  ·  Alzheimer Disease (3)  ·  Fatty Liver (3)  ·  Hypertriglyceridemia (3)  ·  Metabolic Syndrome (3)  ·  Aggressive Periodontitis (2)  ·  Anxiety Disorders (2)  ·  Breast Neoplasms (2)  ·  Carcinoma, Intraductal, Noninfiltrating (2)  ·  Depressive Disorder, Major (2)  ·  Diabetes Mellitus (2)

Sponsors

Oramed, Ltd. (5)  ·  Oregon Health and Science University (5)  ·  University of Rochester (3)  ·  Icahn School of Medicine at Mount Sinai (2)  ·  National Heart, Lung, and Blood Institute (NHLBI) (2)  ·  October 6 University (2)  ·  The Canadian College of Naturopathic Medicine (2)  ·  Universidade Estadual Paulista Júlio de Mesquita Filho (2)  ·  University of Cincinnati (2)  ·  Vanderbilt University Medical Center (2)  ·  Wake Forest University Health Sciences (2)  ·  Andrea Bonny (1)  ·  Bambino Gesù Hospital and Research Institute (1)  ·  Boston Children's Hospital (1)  ·  Charite University, Berlin, Germany (1)

Countries

United States (47)  ·  Canada (8)  ·  Brazil (2)  ·  Egypt (2)  ·  China (1)  ·  Finland (1)  ·  Germany (1)  ·  Holy See (1)  ·  Israel (1)  ·  Mexico (1)  ·  Portugal (1)  ·  Russia (1)  ·  United Kingdom (1)

Top investigators

Joel M Neutel, M. D. (4)  ·  Lynne Shinto, ND, MPH (4)  ·  Marcelo J Amar, M.D. (2)  ·  Mauro Santamaria, Professor (2)  ·  Miriam Kidron, Ph.D. (2)  ·  Robert C Block, MD, MPH (2)  ·  Robert McNamara, PhD (2)  ·  Vilma Gabbay, M.D. (2)  ·  Alfred E Slonim, MD (1)  ·  Alp Ikizler, MD (1)  ·  Amr M Elkhouli, ass prof (1)  ·  Amr M. Elkhouli, ph.D (1)  ·  Andrea Bonny, MD (1)  ·  Anthony Bier, MD (1)  ·  Arthur J. McCullough, M.D. (1)

Results publications

PMID 17971707, PMID 20667792, PMID 20980771, PMID 21816071, PMID 22136963, PMID 22640930, PMID 23010452, PMID 23453547, PMID 23664596, PMID 23702094, PMID 24077434, PMID 24373610, PMID 24583757, PMID 25195547, PMID 25201887, PMID 25264972, PMID 25393536, PMID 25515553, PMID 25555354, PMID 25771388, PMID 25884846, PMID 26283629, PMID 26696953, PMID 27342748, PMID 29985566, PMID 30541065, PMID 30934894, PMID 33875799, PMID 33933722, PMID 34906201, PMID 36351465, PMID 37404855, PMID 38775255, PMID 39088212, PMID 39131144, PMID 39171074

NIH funding

M01RR000334 (1), P30CA012197 (1), R01AG029562 (1), R01AG043398 (1), R01HD098719 (1), R21AG023805 (1), R21AT002395 (1), R21AT002901 (1), R21AT003844 (1), R21AT004576 (1), U01AG050499 (1), U01DK061732 (1)